US$ 23.85
2.5 mg tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Yurpeak® Tirzepatide 2.5mg KwikPen -
Description
Weight loss medication was not commonly prescribed in this substance use disorder sample Prescription of these diabetes/weight-loss medications was relatively rare among those with alcohol or opioid use disorder based on clinical diagnosis present in their medical record (see Figure below)

B., Popli, P., Maurya, V

Invest 106 , 165169 (2000)

The cherry on top is that neither of them can currently produce enough medicine to meet the demand

PlexusDx accepts HSA/FSA and requires no insurance, making treatment accessible regardless of coverage status
